On 8 June 2015

Shasun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 June 2015 to consider conversion of 71,00,000 convertible warrants into equity shares of the Company issued to M/s. Sequent Scientific Limited, Mumbai on preferential basis.

Powered by Capital Market - Live News

More From This Section

First Published: Jun 03 2015 | 2:35 PM IST

Next Story